VaxInnate
Advancing the future of healthcare with innovative vaccines for flu, malaria, dengue, papillomavirus, and respiratory syncytial virus since 2002.
General Information
BounceWatch is an independent company data service, not affiliated with VaxInnate. To contact VaxInnate, visit vaxinnate.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does VaxInnate compare?
A PDF of VaxInnate and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting VaxInnate soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is VaxInnate on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About VaxInnate
Business keywords: Vaccine development, Flu vaccine, Malaria vaccine, Dengue vaccine, Papillomavirus vaccine, Respiratory syncytial virus vaccine, Health diagnostics, Innovative healthcare solutions, Bioinnovation, New Jersey-based company, Vaccine technology, Disease prevention, Immunization research
Funding Rounds & Investors (9)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $3.25M | - |
|
28 Sep 2015 |
| Venture Round | $6.00M | 1 |
|
02 Oct 2014 |
| Grant | $2.10M | - |
|
28 Jan 2014 |
| Grant | $2.20M | 1 |
National Institute of Allergy and Infectious Diseases
|
04 Apr 2013 |
| Debt Financing | $24.81M | - |
|
24 Feb 2012 |
| Series D | $30.00M | 7 |
|
14 Jun 2009 |
| Series C | $40.00M | 1 |
|
25 Oct 2006 |
| Series B | $23.10M | - |
|
12 Mar 2004 |
| Series A | $1.00M | - |
|
28 May 2002 |
VaxInnate Alternatives & Competitors
View All Alternatives
HilleVax is a biopharmaceutical company focused on the development and commercialization of novel va...
Transforming vaccine efficacy in respiratory disease.
Profectus BioSciences is an innovative clinical stage vaccine company devoted to preventing and trea...
FAQ About VaxInnate
Source: BounceWatch company record for VaxInnate, https://bouncewatch.com/company/vaxinnate, updated 26 December 2024. When citing, please name BounceWatch and link this page.
